Skip to content

Comparison of suppressive hormonal therapy(LD tablet) with aspiration in regression of ovarian endometrioma

Comparison of suppressive hormonal therapy(LD tablet) with aspiration in regression of ovarian endometrioma

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201609105563N8
Enrollment
50
Registered
2016-10-02
Start date
2016-10-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis of ovary. Endometriosis of ovary

Interventions

Intervention 1: In intervention group A: LD tablets daily for three months a number. Intervention 2: The intervention group B: Aspiration of the cyst.
Treatment - Drugs
Treatment - Other
In intervention group A: LD tablets daily for three months a number
The intervention group B: Aspiration of the cyst

Sponsors

Vice chancellor for Research,Tabriz University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: womens aged 15-45; unilateral endometrioma, endometrioma diagnosis with ultrasound; CA 125<100; mass size less than or equal to 6 cm Exclusion criteria: the possibility of malignancy; contraindications of LD pill; ischemic heart disease or previous history of it; current breast cancer; liver tumors (benign and malignant))

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Size of the cyst. Timepoint: One, three and six months after treatment. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Dysmenorrhea. Timepoint: One, three and six months after treatment. Method of measurement: Questionnaire.;Dyspareunia. Timepoint: One, three and six months after treatment. Method of measurement: Questionnaire.;Pelvic pain. Timepoint: One, three and six months after treatment. Method of measurement: (Incontinence quality of life =I-QOL).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElaheh Ouladsahebmadarek

Tabriz University Of Medical Sciences

lahroudin@gmail.com+98 41 3553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026